Work

Impaired Hepatic Insulin Clearance Links Fatty Liver Disease to Atherosclerosis

Year: 2018
Type: article
Abstract: Insulin resistance has long been considered to play a crucial role in the pathophysiology of metabolic syndrome that is the leading cause of mortality and morbidity worldwide.Metabolic diseases consist of a group of metabolic abnormalities that increase the risk of health problems, such as type 2 diabetes (T2D) and cardiovascular disease.Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and metabolic syndromes.It is the fastest growing cause of liver dysfunction.Its progressive form nonalcoholic steatohepatitis (NASH) is associated with hepatic fibrosis that can develop into cirrhosis.In addition, there is a growing body of evidence that among risk factors that promote atherosclerosis, metabolic syndrome is a potent predictor of cardiovascular events.Insulin resistance seems to play a major role in the pathophysiology of atherosclerosis in relation with metabolic syndrome.Given that patients with NAFLD/NASH are at a high risk to develop atherosclerosis; these two diseases may share some pathology.However, precise molecular mechanisms underlying the pathogenesis and progression of these diseases are not well understood.Thus studying the molecular link between them would pinpoint sites of more effective pharmacologic interventions.The carcinoembryonic antigen-related cell adhesion guidance, support, invaluable expertise and immense knowledge.They were my motivation and inspiration throughout my PhD and helped me in pursing my goals.My warmest thanks go to all my committee members for their constructive advice, effort and guidance.I deeply
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: green
OpenAlex ID: W7066481381
FWCI:
Cites: 332
Cited by:
Related to: 10